ÂÜÀòÂÒÂ×

John Curnutte is a seasoned professional in the biotech and therapeutics sectors, holding several influential roles including Board Member at Cayuga Biotech and Orchard Therapeutics, and Senior Advisor at Samsara BioCapital. Additionally, John serves as a SAB Member at Autobahn Labs, Inc. and is on the Board of Directors at Pliant Therapeutics. John Curnutte's academic credentials include an M.D. and Ph.D. from Harvard Medical School, completed between 1973 and 1980, and an A.B. in Biochemistry and Molecular Biology from Harvard University, earned from 1969 to 1973.